Navigation Links
AAPS and PhRMA co-sponsor stability workshop
Date:9/16/2009

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, and opportunities for networking and professional development. This workshop is co-sponsored with the Pharmaceutical Research and Manufacturers of America (PhRMA).

WHAT: In partnership with PhRMA, AAPS is pleased to present the workshop Current Trends in Stability Challenges with Today's New Products. This two-day event will address the complex role of stability evaluation in today's pharmaceutical development process and ongoing manufacturing environment, as well as some of the challenges scientists will face in all processes. The workshop will consist of talks by experts from the pharmaceutical industry, the World Health Organization and the U.S. Food and Drug Administration.

WHY: This workshop will bring together scientists and regulators from around the world to discuss current requirements, and best practices to address challenges in areas such as: stability by design and applications of new technologies to stability evaluation. Attendees will participate in four session tracks highlighting stability by design, stability strategies for drug device combinations and protein and biotech products, as well as regulatory harmonization of worldwide stability requirements.

WHEN:
September 24-25, 2009
Gaylord National Resort & Convention Center
National Harbor, MD

CONTACT: For additional information about the workshop, and to register, visit http://www.aapspharmaceutica.com/StabilityTrends. To set up an interview with a workshop speaker please contact Joe Catapano at 703-248-4772 or CatapanoJ@aaps.org.


'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Related biology news :

1. FDLI, PEN co-sponsor major conference on nanotechnology
2. Great Plains historical stability vulnerable to future changes
3. Predators and parasites may increase evolutionary stability
4. Human RecQ helicases, homologous recombination and genomic instability
5. Seeking sustainability in a world of instability
6. Breast cancer genome shows evolution, instability of cancer
7. Making a point: Picoscale stability in a room-temperature AFM
8. Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
9. Temporary infidelity may contribute to the stability of ancient relationships
10. The downside of microtubule stability
11. Corn yield stability varies with rotations, fertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology: